National Institute on Drug Abuse; Notice of Closed Meetings, 3216-3217 [05-1076]
Download as PDF
<![CDATA[
3216
Federal Register / Vol. 70, No. 13 / Friday, January 21, 2005 / Notices
Review Branch, Division of Extramural
Research, National Inst. of Dental and
Craniofacial Research, National Institutes of
Health, 45 Center Dr., room 4AN32E,
Bethesda, MD 20892, (301) 451–5096.
Name of Committee: National Institute of
Dental and Craniofacial Research Special
Emphasis Panel; 05–40, Review R03s.
Date: March 1, 2005.
Time: 10 a.m. to 11 a.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive, Bethesda,
MD 20892, (Telephone Conference Call).
Contact Person: Lynn M. King, PhD,
Scientific Review Administrator, Scientific
Review Branch, 45 Center Dr., room 4AN–
38K, National Institute of Dental and
Craniofacial Research, National Institutes of
Health, Bethesda, MD 20892–6402, (301)
594–5006.
Name of Committee: National Institute of
Dental and Craniofacial Research Special
Emphasis Panel; 05–38, Review K23s.
Date: March 3, 2005.
Time: 1 p.m. to 2 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive, Bethesda,
MD 20892, (Telephone Conference Call).
Contact Person: Lynn M. King, PhD,
Scientific Review Administrator, Scientific
Review Branch, 45 Center Dr., room 4AN–
38K, National Institutes of Dental and
Craniofacial Research, National Institutes of
Health, Bethesda, MD 20892–6402, (301)
594–5006.
Name of Committee: National Institute of
Dental and Craniofacial Research Special
Emphasis Panel; 05–37, Review K22s.
Date: April 4, 2005.
Time: 1 p.m. to 2 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive, Bethesda,
MD 20892, (Telephone Conference Call).
Contact Person: Lynn M. King, PhD,
Scientific Review Administrator, Scientific
Review Branch, 45 Center Dr., room 4AN–
38K, National Institute of Dental and
Craniofacial Research, National Institutes of
Health, Bethesda, MD 20892–6402, (301)
594–5006.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.121, Oral Diseases and
Disorders Research, National Institutes of
Health, HHS)
Dated: January 13, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–1075 Filed 1–19–05; 8:45 am]
BILLING CODE 4140–01–M
VerDate jul<14>2003
14:11 Jan 19, 2005
Jkt 205001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse;
Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel;
‘‘Mucosal Delivery of Drugs Using Novel
Film Composites (STRIP)’’.
Date: January 19, 2005.
Time: 1:30 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6101
Executive Boulevard, Rockville, MD 20852,
(Telephone Conference Call.)
Contact Person: Eric Zatman, Contract
Review Specialist, Office of Extramural
Affairs, National Institute on Drug Abuse,
NIH, DHHS, Room 220, MSC 8401, 6101
Executive Boulevard, Bethesda, MD 20892–
8401, (301) 435–1438.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel,
‘‘Clinical Coordinating Center for NIDA
Clinical Trials Network’’.
Date: January 25, 2005.
Time: 9 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Double Tree Rockville, 1750
Rockville Pike, Rockville, MD 20852.
Contact Person: Richard C. Harrison, Chief,
Contract Review Branch, Office of Extramural
Affairs, National Institute on Drug Abuse,
NIH, DHHS, Room 220, MSC 8401, 6101
Executive Boulevard, Bethesda, MD 20892–
8401, (301) 435–1437.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel, SBIR—
‘‘Prevention Training’’.
Date: January 25, 2005.
Time: 9 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
PO 00000
Frm 00035
Fmt 4703
Sfmt 4703
Place: Residence Inn Bethesda, 7335
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Lyle Furr, Contract Review
Specialist, Office of Extramural Affairs,
National Institute on Drug Abuse, NIH,
DHHS, Room 220, MSC 8401, 6101 Executive
Boulevard, Bethesda, MD 20892–8401, (301)
435–1439.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel, ‘‘A Low
Cost Novel Imaging System for
Neuroscience’’.
Date: January 26, 2005.
Time: 1:30 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6101
Executive Boulevard, Rockville, MD 20852,
(Telephone Conference Call).
Contact Person: Eric Zatman, Contract
Review Specialist, Office of Extramural
Affairs, National Institute on Drug Abuse,
NIH, DHHS, Room 220, MSC 8401, 6101
Executive Boulevard, Bethesda, MD 20892–
8401, (301) 435–1438.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel, ‘‘SBIR
Phase II–‘‘Multi-Problem Youth Screening
Assessment Package’’.
Date: February 1, 2005.
Time: 9:30 a.m. to 11:30 a.m.
Agenda: To review and evaluate contract
proposals.
Place: National of Institutes of Health, 6101
Executive Boulevard, Rockville, MD 20852,
(Telephone Conference Call).
Contact Person: Lyle Furr, Contract Review
Specialist, Office of Extramural Affairs,
National Institute on Drug Abuse, NIH,
DHHS, Room 220, MSC 8401, 6101 Executive
Boulevard, Bethesda, MD 20892–8401, (301)
435–1439.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel, ‘‘Data
and Statistics Center for CTN’’.
Date: February 8–9, 2005.
Time: 9 a.m. to 5 p.m.
Agenda: To review and evaluate contract
proposals.
Place: Double Tree Rockville, 1750
Rockville Pike, Rockville, MD 20852.
Contact Person: Eric Zatman, Contract
Review Specialist, Office of Extramural
Affairs, National Institute on Drug Abuse,
NIH, DHHS, Room 220, MSC 8401, 6101
Executive Boulevard, Bethesda, MD 20892–
8401, (301) 435–1438.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel, SBIR—
‘‘Development of Science Education
Materials or Programs’’.
Date: February 15, 2005.
Time: 9 a.m. to 5 p.m.
E:\FR\FM\21JAN1.SGM
21JAN1
Federal Register / Vol. 70, No. 13 / Friday, January 21, 2005 / Notices
Agenda: To review and evaluate contract
proposals.
Place: Residence Inn Bethesda, 7335
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Lyle Furr, Contract Review
Specialist, Office of Extramural Affairs,
National Institute on Drug Abuse, NIH,
DHHS, Room 220, MSC 8401, 6101 Executive
Boulevard, Bethesda, MD 20892–8401, (301)
435–1439.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel, SBIR—
‘‘Develop New Technologies for Screening
and Assessing Drug Abuse and Matching
Patients with Appropriate Treatment
Services’’.
Date: March 15, 2005.
Time: 9 a.m. to 5 p.m.
Agenda: To review and evaluate contract
proposals.
Place: Double Tree Rockville, 1750
Rockville Pike, Rockville, MD 20852.
Contact Person: Lyle Furr, Contract Review
Specialist, Office of Extramural Affairs,
National Institute on Drug Abuse, NIH,
DHHS, Room 220, MSC 8401, 6101 Executive
Boulevard, Bethesda, MD 20892–8401, (301)
435–1439.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.277, Drug Abuse Scientist
Development Award for Clinicians, Scientist
Development Awards, and Research Scientist
Awards; 93.278, Drug Abuse National
Research Service Awards for Research
Training; 93.279, Drug Abuse Research
Programs, National Institutes of Health, HHS)
Dated: January 12, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–1076 Filed 1–19–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HOMELAND
SECURITY
Coast Guard
[CGD08–04–045]
Houston-Galveston Area Maritime
Security Committee
Coast Guard, DHS.
Solicitation for membership.
AGENCY:
ACTION:
SUMMARY: This notice requests
individuals interested in serving on the
Houston-Galveston Area Maritime
Security Committee (AMSC) to submit
their application for membership to the
COTP Houston-Galveston. The AMSC
advises and assists the HoustonGalveston Federal Maritime Security
Coordinator (FMSC) in developing the
Area Maritime Security Plan for the
Ports of Houston, Texas City, Freeport,
and Galveston. Specific vacancies are
listed under supplemental information.
DATES: Requests for membership should
reach the U.S. Coast Guard Captain of
VerDate jul<14>2003
14:11 Jan 19, 2005
Jkt 205001
the Port Houston-Galveston on or before
February 22, 2005.
ADDRESSES: Applications for
membership should be submitted to the
Captain of the Port at the following
address: MSO Houston-Galveston,
AMSC Executive Administrator, P.O.
Box 446, Galena Park, TX 77547–0446.
AMSC meetings are currently held at
the Port of Houston Authority, 111 East
Loop, Houston, TX.
FOR FURTHER INFORMATION CONTACT: For
questions about submitting an
application or about the AMSC in
general, contact Ms. Tobi Moore, AMSC
Executive Administrator, at 713–671–
5118.
SUPPLEMENTARY INFORMATION:
Authority
Section 102 of the Maritime
Transportation Security Act (MTSA) of
2002 (Pub. L. 107–295) added section
70112 to Title 46 of the U.S. Code, and
authorizes the Secretary of the
Department in which the Coast Guard is
operating to establish AMSCs for any
port area of the United States. (See 33
U.S.C. 1226; 46 U.S.C Chapter 701; 33
CFR 1.05–1, 6.01; Department of
Homeland Security Delegation No.
0170.1). The MTSA includes a provision
exempting these AMSCs from the
Federal Advisory Committee Act
(FACA), Public Law 92–436, 86 Stat.
470 (5 U.S.C. App.2).
The AMSCs shall assist the FMSC in
the review and update of the AMS Plan
for the Houston, Galveston, Freeport
and Texas City area of responsibility.
Such matters may include, but are not
limited to: Identifying critical port
infrastructure and operations;
Identifying risks (threats,
vulnerabilities, and consequences);
Determining mitigation strategies and
implementation methods; Developing
and describing the process to
continually evaluate overall port
security by considering consequences
and vulnerabilities, how they may
change over time, and what additional
mitigation strategies can be applied; and
Providing advice to, and assisting the
FMSC in, reviewing and updating the
Houston-Galveston Area Maritime
Security Plan.
AMS Committee Membership
At least seven of the members of the
AMSC must have at least five years of
experience related to maritime or port
security operations. We are seeking to
fill the following vacancies with this
solicitation:
(1) Texas City Port Police
representative primary and alternate;
PO 00000
Frm 00036
Fmt 4703
Sfmt 4703
3217
(2) Galveston Port Police
representative, alternate;
(3) Freeport Port Police
representative, primary and alternate;
(4) Galveston and Harris County Law
Enforcement representative, primary
and alternate (other counties
surrounding waterways are eligible);
(5) Trucking industry, primary;
(6) Offshore carriers, alternate; and
(7) City Police Department—multiple
opportunities (any city surrounding
waterways are eligible) primary and
alternate.
Applicants may be required to pass an
appropriate security background check
prior to appointment to the committee.
Members’ terms of office will be for
five years; however, a member is eligible
to serve an additional term or office.
Members serve voluntarily and will not
receive any salary or other
compensation for their service on the
AMS Committee from the Federal
Government.
In support of the policy of the USCG
on gender and ethnic diversity, we
encourage qualified women and
members of minority groups to apply.
Meetings
The AMSC meets the last Thursday of
odd-numbered months. Subcommittees
and work groups convene between
meetings of the parent committee.
AMSC meetings start at 9 a.m. and are
currently held at the Port of Houston
Authority, 111 East Loop, Houston, TX.
Request for Applications
It is requested that applicants possess
experience related to maritime or port
security operations. Those seeking
membership are not required to submit
formal applications to the local FMSC,
however, because we do have an
obligation to ensure that a specific
number of members have the
prerequisite maritime security
experience, we encourage the
submission of resumes highlighting
experience in the maritime and security
industries.
Dated: December 28, 2004.
Kevin L. Marshall,
Captain, U.S. Coast Guard, Acting
Commander, 8th Coast Guard Dist.
[FR Doc. 05–1150 Filed 1–19–05; 8:45 am]
BILLING CODE 4910–15–P
E:\FR\FM\21JAN1.SGM
21JAN1
]]>Agencies
[Federal Register Volume 70, Number 13 (Friday, January 21, 2005)]
[Notices]
[Pages 3216-3217]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-1076]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended. The contract proposals and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the contract proposals, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel; ``Mucosal Delivery of Drugs Using Novel Film
Composites (STRIP)''.
Date: January 19, 2005.
Time: 1:30 p.m. to 4 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6101 Executive Boulevard,
Rockville, MD 20852, (Telephone Conference Call.)
Contact Person: Eric Zatman, Contract Review Specialist, Office
of Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS,
Room 220, MSC 8401, 6101 Executive Boulevard, Bethesda, MD 20892-
8401, (301) 435-1438.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel, ``Clinical Coordinating Center for NIDA Clinical
Trials Network''.
Date: January 25, 2005.
Time: 9 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Double Tree Rockville, 1750 Rockville Pike, Rockville, MD
20852.
Contact Person: Richard C. Harrison, Chief, Contract Review
Branch, Office of Extramural Affairs, National Institute on Drug
Abuse, NIH, DHHS, Room 220, MSC 8401, 6101 Executive Boulevard,
Bethesda, MD 20892-8401, (301) 435-1437.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel, SBIR--``Prevention Training''.
Date: January 25, 2005.
Time: 9 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda,
MD 20814.
Contact Person: Lyle Furr, Contract Review Specialist, Office of
Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS,
Room 220, MSC 8401, 6101 Executive Boulevard, Bethesda, MD 20892-
8401, (301) 435-1439.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel, ``A Low Cost Novel Imaging System for
Neuroscience''.
Date: January 26, 2005.
Time: 1:30 p.m. to 4 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6101 Executive Boulevard,
Rockville, MD 20852, (Telephone Conference Call).
Contact Person: Eric Zatman, Contract Review Specialist, Office
of Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS,
Room 220, MSC 8401, 6101 Executive Boulevard, Bethesda, MD 20892-
8401, (301) 435-1438.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel, ``SBIR Phase II-``Multi-Problem Youth Screening
Assessment Package''.
Date: February 1, 2005.
Time: 9:30 a.m. to 11:30 a.m.
Agenda: To review and evaluate contract proposals.
Place: National of Institutes of Health, 6101 Executive
Boulevard, Rockville, MD 20852, (Telephone Conference Call).
Contact Person: Lyle Furr, Contract Review Specialist, Office of
Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS,
Room 220, MSC 8401, 6101 Executive Boulevard, Bethesda, MD 20892-
8401, (301) 435-1439.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel, ``Data and Statistics Center for CTN''.
Date: February 8-9, 2005.
Time: 9 a.m. to 5 p.m.
Agenda: To review and evaluate contract proposals.
Place: Double Tree Rockville, 1750 Rockville Pike, Rockville, MD
20852.
Contact Person: Eric Zatman, Contract Review Specialist, Office
of Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS,
Room 220, MSC 8401, 6101 Executive Boulevard, Bethesda, MD 20892-
8401, (301) 435-1438.
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel, SBIR--``Development of Science Education Materials
or Programs''.
Date: February 15, 2005.
Time: 9 a.m. to 5 p.m.
[[Page 3217]]
Agenda: To review and evaluate contract proposals.
Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda,
MD 20814.
Contact Person: Lyle Furr, Contract Review Specialist, Office of
Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS,
Room 220, MSC 8401, 6101 Executive Boulevard, Bethesda, MD 20892-
8401, (301) 435-1439.
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel, SBIR--``Develop New Technologies for Screening and
Assessing Drug Abuse and Matching Patients with Appropriate
Treatment Services''.
Date: March 15, 2005.
Time: 9 a.m. to 5 p.m.
Agenda: To review and evaluate contract proposals.
Place: Double Tree Rockville, 1750 Rockville Pike, Rockville, MD
20852.
Contact Person: Lyle Furr, Contract Review Specialist, Office of
Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS,
Room 220, MSC 8401, 6101 Executive Boulevard, Bethesda, MD 20892-
8401, (301) 435-1439.
(Catalogue of Federal Domestic Assistance Program Nos. 93.277, Drug
Abuse Scientist Development Award for Clinicians, Scientist
Development Awards, and Research Scientist Awards; 93.278, Drug
Abuse National Research Service Awards for Research Training;
93.279, Drug Abuse Research Programs, National Institutes of Health,
HHS)
Dated: January 12, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 05-1076 Filed 1-19-05; 8:45 am]
BILLING CODE 4140-01-M
